The current PRME market cap is 363.32M. The company's latest EPS is USD -1.5106 and P/E is -1.80.
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 5.21M | 0 | 0 | 0 |
Operating Income | -932k | -84.47M | -116.54M | -204.79M |
Net Income | -5.06M | -184.12M | -142.01M | -198.13M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 54.78M | 301.86M | 360.31M | 193.85M |
Total Liabilities | 21.31M | 62.3M | 44.04M | 60.78M |
Total Equity | 2.34M | -156.24M | 316.27M | 133.07M |
Market Cap | 363.32M |
Price to Earnings Ratio | -1.80 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 8.58 |
Price to Book Ratio | 2.68 |
Dividend Yield | - |
Shares Outstanding | 131.16M |
Average Volume (1 week) | 1.08M |
Average Volume (1 Month) | 952.12k |
52 Week Change | -59.20% |
52 Week High | 9.77 |
52 Week Low | 2.25 |
Spread (Intraday) | 0.01 (0.36%) |
Company Name | Prime Medicine Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.primemedicine.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions